Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.04 USD | -3.59% | +1.19% | -29.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.00% | 5.29B | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-14.14% | 32.79B | |
+63.37% | 26.23B | |
-21.51% | 14.52B | |
-7.61% | 13.09B | |
-42.60% | 11.6B | |
-12.64% | 11.5B | |
+5.39% | 8.82B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals Says EMA Moves Pegcetacoplan Application to Last Phase of Initial Assessment